Annovis Bio Plans Three Presentations at CTAD Conference
Bitget2026/10/22 12:10- Annovis Bio will deliver three presentations at the Clinical Trials on Alzheimer's Disease conference in Boston, Nov. 16-19, 2026.
- An oral presentation on buntanetap's mechanism of action is scheduled for Nov. 19 at 3:52 p.m. ET.
- Posters cover buntanetap's pivotal early Alzheimer's study and AI-based drug evaluation, displayed Nov. 16, 2 p.m., through Nov. 17, 5:30 p.m. ET.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US), dubbed “Nvidia's protégé,” downplays Jensen Huang’s departure risk: the company is not dependent on an individual, key partnerships remain unchanged
CoreWeave stated that Nvidia does not “belong to any single individual” and remains a key partner for the company.
Barclays, Deutsche Bank, and others: AI boom supports the US dollar, rally expected to continue until 2027
Barclays and Deutsche Bank believe that the artificial intelligence boom will continue to support a strong US dollar.

UniCredit reaches broad agreement with Germany on the acquisition of Commerzbank
ECB President Lagarde speaks next with the Euro under 1.1000